Access Consortium generic work-sharing updates are forcing earlier dossier harmonisation across agencies

Recent MHRA updates to the Access Generic Medicines Work Sharing Initiative and Integrated Scientific Advice materials signal a tighter operating model for evidence teams: align Modules 2 to 5 early, document country-level deltas explicitly, and treat regulator dialogue as a design step rather than a rescue step.